OTC:ZIVO | Free Cash Flow | Zivo Bioscience, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2010-12-31 to 2025-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-03-31-$1.43M
2024-12-31-$905,722.00
2024-03-31-$1.7M
2023-12-31-$715,733.00
2023-03-31-$2.13M
2022-12-31-$1.45M
2022-03-31-$2.86M
2021-12-31-$1.9M
2021-03-31-$1.05M
2020-12-31-$901,479.00
2020-03-31-$783,068.00
2019-12-31-$651,334.00
2019-03-31-$576,234.00
2018-12-31-$1.12M
2018-03-31-$874,000.00
2017-12-31-$1.36M
2017-03-31-$529,485.00
2016-12-31-$819,850.00
2016-03-31-$758,175.00
2015-12-31-$486,527.00
2015-03-31-$401,768.00
2014-12-31-$297,886.00
2014-03-31-$680,531.00
2013-03-31-$556,291.00
2012-12-31-$356,687.00$0.00-$356,687.00
2012-03-31-$534,209.00$0.00-$534,209.00
2011-12-31-$523,686.00$1.00-$523,687.00
2011-03-31-$320,718.00-$3,795.00-$324,513.00

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2024-12-31-$4.31M
2023-12-31-$5.8M
2022-12-31-$7.1M
2021-12-31-$6.8M
2020-12-31-$2.59M
2019-12-31-$3.71M
2018-12-31-$5.01M
2017-12-31-$4.24M
2016-12-31-$2.54M
2015-12-31-$2.3M
2014-12-31-$2.74M
2013-12-31-$2.99M$0.00-$2.99M
2012-12-31-$1.77M-$3,500.00-$1.78M
2011-12-31-$1.29M-$4,720.00-$1.3M
2010-12-31-$1.44M-$29,629.00-$1.47M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.